PROX1 and neoplasm: Using the Pearson’s Chi-square test, there were no statistically significant variations in PROX1 expression concerning the factors; patient age (P = 0.157), gender (P = 0.373), tumor site (P = 0.801), and incidence of mortality (P = 0.078).